Menopause, estrogen, and gonadotropins in Alzheimer's disease (Q37144896)

18 August 2017

1 reference

title

Menopause, estrogen, and gonadotropins in Alzheimer's disease (English)

1 reference

18 August 2017

Menopause, Estrogen, and Gonadotropins in Alzheimer's Disease (English)

0 references

1 reference

6

George Perry

1 reference

18 August 2017

7

Mark A Smith

1 reference

18 August 2017

1

Gemma Casadesus

1 reference

18 August 2017

4

Craig S Atwood

1 reference

18 August 2017

4

Craig S. Atwood

0 references

Raj K Rolston

2

object named as

Raj K Rolston

1 reference

18 August 2017

2

Raj K. Rolston

0 references

Kate Webber

3

object named as

Kate M Webber

1 reference

18 August 2017

3

Kate M. Webber

0 references

Mark Anthony Smith

7

object named as

Mark A. Smith

0 references

author name string

Richard L Bowen

5

1 reference

18 August 2017

Richard L. Bowen

5

0 references

publication date

1 January 2008

1 reference

Advances in Clinical Chemistry

18 August 2017

2008

0 references

published in

1 reference

18 August 2017

45

1 reference

18 August 2017

139-153

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

18 August 2017

1 reference

7 January 2021

Alzheimer Disease in the US Population

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

1 reference

7 January 2021

Effects of aging and task difficulty on divided attention performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Cognitive maps of environmental knowledge and preference in nursing home patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Alzheimer's disease: genotypes, phenotypes, and treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

1 reference

7 January 2021

Amyloid-beta: a (life) preserver for the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer's disease elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Tau aggregation into fibrillar polymers: taupathies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

The role of mitogen-activated protein kinase pathways in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Radical AGEing in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Oxidative damage in Alzheimer's.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Alzheimer's disease: the two-hit hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

The prevalence of dementia: a quantitative integration of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

The incidence of dementia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Age incidence of senile brain amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Estrogen and cognitive functioning in women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Menopause and the central nervous system: intervention options

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Endogenous estrogen levels and Alzheimer's disease among postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Estrogen and cognitive aging in women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Estrogen and cognitive aging in women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Hormone therapy and risk of Alzheimer disease: a critical time.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Estrogen and Cognitive Functioning in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Ovarian steroids and the brain: implications for cognition and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Cyclic changes in estradiol regulate synaptic plasticity through the MAP kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Estradiol increases pre- and post-synaptic proteins in the CA1 region of the hippocampus in female rhesus macaques (Macaca mulatta).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Estrogen and cognition, with a focus on Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Support for a bimodal role for type II adrenal steroid receptors in spatial memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Plasticity of the hippocampus: adaptation to chronic stress and allostatic load.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Stress and hippocampal plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Metabolism of dehydroepiandrosterone by rat hippocampal cells in culture: possible role of aromatization and 7-hydroxylation in neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Steroid Hormones and Cognitive Functioning in Aging Men: A Mini-Review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Higher levels of plasma estradiol and testosterone in healthy elderly men compared with age-matched women may protect aspects of explicit memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Memory loss as reported symptom of andropause.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

1 reference

7 January 2021

The menopause and HRT. HRT and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Earlier onset of Alzheimer's disease in men with Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Estrogen as a treatment for Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Neuroprotective effects of female sex steroids in humans: current controversies and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Sex, hormones, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Hormone therapy and the brain: déjà vu all over again?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

The endocrinology of the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Hormone therapy and Alzheimer's disease: benefit or harm?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

The brain as a target organ of gonadal steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

The control of gonadotrophin secretion by ovarian steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Hormonal profiles after the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Neural actions of luteinizing hormone and human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Estrogen replacement and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Gonadal function in patients with Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

An association of elevated serum gonadotropin concentrations and Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Increased p27, an essential component of cell cycle control, in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Oxidative damage is the earliest event in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Mitochondrial abnormalities in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Targeted cytotoxic analogs of luteinizing hormone-releasing hormone: a reply

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

Increases in luteinizing hormone are associated with declines in cognitive performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2807%2900006-6

7 January 2021

10.1016/S0065-2423(07)00006-6

Identifiers

DOI

0 references

1 reference